Article25: Right to an adequate standard of living

Everyone has the right to a standard of living adequate for the health and well-being of him/herself...

The Universal Declaration of Human Rights
United Nations. December 10, 1948

81f27-DSuo63LW0AEyX2T.jpg
5f589-seniorboomers.jpg
4ef8e-study_abroad_group.jpg

Investment strategy

A diversified portfolio with an optimized risk-reward approach

Meaningful investments in areas of unmet need in healhcare, coordinated to make a substantial social impact within a predefined time frame.

80%

fund capital Flagship Growth

Industrial and healthcare infrastructure, risk-mitigated impactment investment projects

08/02/2019

Advanced Radiotherapy Technologies

Integrated Proton/RT/Imaging centers and technologies
08/02/2019

Nutrition & Health

Columbus Venture Partners
Article25
Investment
portfolio

20%

fund capital Breakthrough

Transformational investments in innovative projects in lifesciences, biotech and technology

Portfolio

News

14/06/2019

NGS Panels in Management of Myeloid-related Diseases

IPBA-led workshop during the 2019 European Hematology Association meeting, Amsterdam
Read more
03/06/2019

Changing the game of precision medicine in the Land of the Rising Sun

Recent changes in the reimbursement system and the strategy of the Ministry of Health are contributing to the current upswing in momentum and pivot towards precision medicine in the clinic in Japan.
Read more

Inflection Point Biomedical Advisors (IPBA) provides effective strategic advice and implement hands-on, innovative projects in Precision Medicine for the pharmaceutical and diagnostics industry, investment and VC funds as well as to EU and US governmental agencies.

IPBA is a key collaborator and vital partner of Article25 Capital

About IPBA